Methods and compositions for the treatment of diseases of the eye
Methods and compositions for prophylaxis and/or treatment of diseases of the eye of a patient resulting angiogenesis in the eye using antagonists of the integrin receptors alphav beta3 and/or alphav beta5. The compositions can be nanoparticles and are administered to the eye by injection into the sc...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BENDER HANS-MARKUS FRIEDLANDER MARTIN WIESNER MATTHIAS LANG ULRICH HAUNSCHILD JUTTA |
description | Methods and compositions for prophylaxis and/or treatment of diseases of the eye of a patient resulting angiogenesis in the eye using antagonists of the integrin receptors alphav beta3 and/or alphav beta5. The compositions can be nanoparticles and are administered to the eye by injection into the sclera of the eye. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US7648959B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US7648959B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US7648959B23</originalsourceid><addsrcrecordid>eNrjZHD0TS3JyE8pVkjMS1FIzs8tyC_OLMnMzytWSMsvUijJSFUoKUpNLMlNzStRyE9TSMksTk0sTi0GsUGSqZWpPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7UkPjTY3MzEwtLU0snImAglAJ6WMWM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Methods and compositions for the treatment of diseases of the eye</title><source>esp@cenet</source><creator>BENDER HANS-MARKUS ; FRIEDLANDER MARTIN ; WIESNER MATTHIAS ; LANG ULRICH ; HAUNSCHILD JUTTA</creator><creatorcontrib>BENDER HANS-MARKUS ; FRIEDLANDER MARTIN ; WIESNER MATTHIAS ; LANG ULRICH ; HAUNSCHILD JUTTA</creatorcontrib><description>Methods and compositions for prophylaxis and/or treatment of diseases of the eye of a patient resulting angiogenesis in the eye using antagonists of the integrin receptors alphav beta3 and/or alphav beta5. The compositions can be nanoparticles and are administered to the eye by injection into the sclera of the eye.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100119&DB=EPODOC&CC=US&NR=7648959B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100119&DB=EPODOC&CC=US&NR=7648959B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BENDER HANS-MARKUS</creatorcontrib><creatorcontrib>FRIEDLANDER MARTIN</creatorcontrib><creatorcontrib>WIESNER MATTHIAS</creatorcontrib><creatorcontrib>LANG ULRICH</creatorcontrib><creatorcontrib>HAUNSCHILD JUTTA</creatorcontrib><title>Methods and compositions for the treatment of diseases of the eye</title><description>Methods and compositions for prophylaxis and/or treatment of diseases of the eye of a patient resulting angiogenesis in the eye using antagonists of the integrin receptors alphav beta3 and/or alphav beta5. The compositions can be nanoparticles and are administered to the eye by injection into the sclera of the eye.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHD0TS3JyE8pVkjMS1FIzs8tyC_OLMnMzytWSMsvUijJSFUoKUpNLMlNzStRyE9TSMksTk0sTi0GsUGSqZWpPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7UkPjTY3MzEwtLU0snImAglAJ6WMWM</recordid><startdate>20100119</startdate><enddate>20100119</enddate><creator>BENDER HANS-MARKUS</creator><creator>FRIEDLANDER MARTIN</creator><creator>WIESNER MATTHIAS</creator><creator>LANG ULRICH</creator><creator>HAUNSCHILD JUTTA</creator><scope>EVB</scope></search><sort><creationdate>20100119</creationdate><title>Methods and compositions for the treatment of diseases of the eye</title><author>BENDER HANS-MARKUS ; FRIEDLANDER MARTIN ; WIESNER MATTHIAS ; LANG ULRICH ; HAUNSCHILD JUTTA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US7648959B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BENDER HANS-MARKUS</creatorcontrib><creatorcontrib>FRIEDLANDER MARTIN</creatorcontrib><creatorcontrib>WIESNER MATTHIAS</creatorcontrib><creatorcontrib>LANG ULRICH</creatorcontrib><creatorcontrib>HAUNSCHILD JUTTA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BENDER HANS-MARKUS</au><au>FRIEDLANDER MARTIN</au><au>WIESNER MATTHIAS</au><au>LANG ULRICH</au><au>HAUNSCHILD JUTTA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Methods and compositions for the treatment of diseases of the eye</title><date>2010-01-19</date><risdate>2010</risdate><abstract>Methods and compositions for prophylaxis and/or treatment of diseases of the eye of a patient resulting angiogenesis in the eye using antagonists of the integrin receptors alphav beta3 and/or alphav beta5. The compositions can be nanoparticles and are administered to the eye by injection into the sclera of the eye.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US7648959B2 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Methods and compositions for the treatment of diseases of the eye |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T00%3A27%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BENDER%20HANS-MARKUS&rft.date=2010-01-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS7648959B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |